Cerevrovascular disease
Conditions
Interventions
None listed
Sponsors
Yokohama Stroke and Brain Ccenter
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: None
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum alfa-GAL activity, serum Lyso-Gb3, gene | — |
Countries
Japan
Contacts
Public ContactRyoko Imazeki
Yokohama Stroke and Brain Center Neurology
Outcome results
None listed